• Gene deletion; HGNC; HGNC:583; APC; Zygosity=Homozygous (PubMed=12204677).
  
• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=12204677; PubMed=17708598).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Heterozygous (PubMed=17708598).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; c.1100+30A>T; ClinVar=VCV000810938; Zygosity=Heterozygous (PubMed=17708598).
  

PubMed=12204677; DOI=10.1016/S0959-8049(02)00158-2
Maria Richter, Daniela Jurek, Fritz Wrba, Klaus Kaserer, Gabriele Wurzer, Judith Karner-Hanusch, Brigitte Marian;
Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro.
Eur. J. Cancer 38:1937-1945(2002)

PubMed=12714179; DOI=10.1016/S0027-5107(03)00012-5
Anja Schaeferhenrich, Gabriele Beyer-Sehlmeyer, Grit Festag, Alma Kuechler, Natja Haag, Anja Weise, Thomas Liehr, Uwe Claussen, Brigitte Marian, Wolfgang Sendt, Johannes Scheele, Beatrice Louise Pool-Zobel;
Human adenoma cells are highly susceptible to the genotoxic action of 4-hydroxy-2-nonenal.
Mutat. Res. 526:19-32(2003)

PubMed=17708598; DOI=10.1002/path.2220
Axel Schulenburg, P. Cech, Irene Herbacek, Brigitte Marian, Fritz Wrba, Peter Valent, Herbert Ulrich-Pur;
CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
J. Pathol. 213:152-160(2007)

DOI=10.25365/thesis.6275
Inga Koneczny;
Investigating a model cell line for tumour stem cells in colorectal cancer.
Thesis MSc (2009); University of Vienna; Vienna; Austria

PubMed=27996158; DOI=10.1002/mc.22606
Wiebke Schlormann, Julia Lamberty, Stefan Lorkowski, Diana Ludwig, Henning Mothes, Christian Saupe, Michael Glei;
Chemopreventive potential of in vitro fermented nuts in LT97 colon adenoma and primary epithelial colon cells.
Mol. Carcinog. 56:1461-1471(2017)